# Aspirin and Statins for Prevention of Atherosclerosis and Arterial Thromboembolism in Systemic Lupus Erythematosus

> **NCT00371501** · PHASE4 · COMPLETED · sponsor: **Tuen Mun Hospital** · enrollment: 72 (actual)

## Conditions studied

- Atherosclerosis
- Thromboembolism
- Systemic Lupus Erythematosus

## Interventions

- **DRUG:** Rosuvastatin
- **DRUG:** placebo
- **DRUG:** aspirin
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT00371501
- **Lead sponsor:** Tuen Mun Hospital
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-06
- **Primary completion:** 2009-12
- **Final completion:** 2009-12
- **Target enrollment:** 72 (ACTUAL)
- **Last updated:** 2010-09-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00371501

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00371501, "Aspirin and Statins for Prevention of Atherosclerosis and Arterial Thromboembolism in Systemic Lupus Erythematosus". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00371501. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*